Article
The cytokine network in acute myeloid leukemia
28 Sept 2022
Abstract excerpt
Acute myeloid leukemia (AML) is a highly heterogeneous malignancy of the blood and bone marrow, characterized by clonal expansion of myeloid stem and progenitor cells and rapid disease progression. Chemotherapy has been the first-line treatment for AML for more than 30 years. Application of recent high-throughput next-generation sequencing technologies has revealed significant molecular heterogeneity to AML,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
